How to Buy Ligand Pharmaceuticals Stock
Ligand Pharmaceuticals Inc
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide.
Ligand Pharmaceuticals stock last closed at $104.97, up 0.33% from the previous day, and has increased 33.09% in one year. It has overperformed other stocks in the Biotechnology industry by 1.12 percentage points. Ligand Pharmaceuticals stock is currently +55.01% from its 52-week low of $67.72, and -19.19% from its 52-week high of $129.90.
There are currently 19.26M shares of LGND outstanding. The market capitalization of LGND is $2.02B. In the last 24 hours, 105,130 LGND shares were traded.
How to Buy Ligand Pharmaceuticals Stock
Wondering how to invest in Ligand Pharmaceuticals stock? Here's how.
- Decide where to buy Ligand Pharmaceuticals stock: You need to pick a stock brokerage, but don't worry - we've tried dozens of stock brokerages and apps to help you choose where to buy Ligand Pharmaceuticals stock.
- Sign up for a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
- Deposit funds into your investment account: Select your method of payment and add your information.
- Research Ligand Pharmaceuticals stock: The Ligand Pharmaceuticals ticker symbol is LGND. Is Ligand Pharmaceuticals stock a good investment? Should you buy shares of LGND? How do LGND's underlying business fundamentals look? Do top analysts think Ligand Pharmaceuticals is a good buy? Why has LGND's stock price moved recently? (Hint: Our stock research tools can help you figure out if LGND is a good stock to buy).
- Execute your LGND trade: Decide if you will purchase LGND shares at the current market price or use a limit order to purchase LGND stock at a specific price.
- Watch your investment in LGND: Create a watchlist to important notifications about your investment in Ligand Pharmaceuticals shares.
Step 1: Decide where to buy Ligand Pharmaceuticals stock
You will need an online brokerage account in order to access the NASDAQ market and buy LGND shares.
Our favorite brokerage: eToro
Based on our analysis, eToro is the best brokerage. eToro gives you:
- You can invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
- Access to world markets: From Technology to Real Estate, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top exchanges.
- Social investing: eToro offers a community of more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your share purchase by signing up for an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Sign up for a brokerage account
Now that you've selected the best brokerage, you'll need to fill out some personal details so you are able to invest in LGND stock today.
How to Start a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal data to open your new trading account.
- Submit your application by pressing the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your investment account
Now that you've opened your account on the highest rated stock app, you need to deposit funds:
Check out the video below if you need help transferring money into your investment account.
Step 4: Research Ligand Pharmaceuticals stock
Once you have figured out the best place to buy Ligand Pharmaceuticals stock, it's important to analyze their stock before you buy, so you can comprehend the risk as well as the upside.
Ligand Pharmaceuticals stock quick numbers
LGND Due Diligence Checks
WallStreetZen was built to help part-time investors perform more accurate fundamental analysis.
You can view all of the due diligence checks on LGND's stock page.
What is the fair value of LGND stock?
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge LGND's fair value.
Using relative valuations ratios:
- LGND could be undervalued based on its P/B ratio of 2.43x, relative to Biotechnology industry P/B ratio of 4.05x
You can access additional valuation analysis on LGND's stock here.
LGND Financial Health Overview
Positive Health Checks:
- LGND has a low debt to equity ratio of 0.13.
- Total LGND debt is lower than 5 years ago, relative to shareholder equity.
- There are more short-term assets than long-term liabilities on the LGND balance sheet.
- There are more short-term assets than short-term liabilities on the LGND balance sheet.
- LGND's operating cash flow of $97.05M allows it to safely service it's debt of $7.11M.
Negative Health Checks:
- LGND profit margin has gone down from 39.7% to -2.4% in the past year.
- LGND earnings of $5.56M is not enough to cover its interest payments.
Is LGND stock a Buy, Hold, or Sell, according to Wall Street analysts?
Out of 6 sell side analysts who research LGND, the consensus analyst rating on Ligand Pharmaceuticals is a Strong Buy
Please note that analyst ratings are not stock recommendations, nor are they investment advice.
Latest LGND Analyst Upgrades/Downgrades
Joseph Pantginis, a bottom 1% analyst from HC Wainwright & Co. reiterates LGND with a buy rating and maintains their LGND price target from $157.00 to $157.00, on Nov 8, 2024.
You can dive deeper into what analysts are projecting on the Ligand Pharmaceuticals stock forecast page.
LGND Technical Indicators
LGND Growth Numbers
Last year, LGND revenue was $167.13M. During the past five year, LGND's revenue has gone up by 6.8% per year. This was slower than the Biotechnology industry average of 44.43%.
Find out more about LGND's earnings and revenue performance here.
Are LGND insiders buying or selling the stock?
In the last year, insiders at LGND have sold more shares than they have bought.
Stephen L. Sabba, Director of LGND, was the latest LGND insider to buy. They bought $125,833.80 worth of LGND stock on Apr 1, 2025.
Research more about who owns LGND stock here.
Does LGND provide a stable income stream?
No, Ligand Pharmaceuticals doesn't provide an income stream by paying out dividends.
LGND Social Trading Data
One of the biggest reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to see what other investors have to say.
Step 5: Execute your LGND trade
There are two primary types of orders:
- Market order: A market order is an order to buy or sell a stock at the best price on the market.
Market orders are usually sufficient. - Limit order: A limit order enables you to buy or sell a security at a specific price (or better).
If you want to be sure you're buying or selling at a given dollar amount, place a limit order.
Hit the Open button and your broker will place the order.
If you need additional assistance buying stocks on eToro, watch the how to video below:
Step 6: Watch your investment in LGND
Now that you own some LGND stock, you'll want to stay up-to-date on your new company.
Make a watchlist to get notified of the latest news about your LGND stock.
LGND Feed
How to Buy Stock in Ligand Pharmaceuticals
To summarize, here are the 6 steps for buying Ligand Pharmaceuticals stock:
- Decide where to buy Ligand Pharmaceuticals stock
- Sign up for a brokerage account
- Deposit funds into your investment account
- Research Ligand Pharmaceuticals stock
- Execute your LGND trade
- Watch your investment in LGND
If you are looking for a online brokerage, eToro is our recommended option.
Get Started with eToro TodayIf you would like to keep an eye on your investment in Ligand Pharmaceuticals, get started below.
More "How To" Guides You Might Find Useful
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.